S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. - Wikidata - wikimedia - TriplyDB

S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.

S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.

http://www.wikidata.org/entity/Q33941051

about

Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor Cyclins in breast cancer: too much of a good thing.Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events Chemical Composition and In Vitro Cytotoxicity of Essential Oils from Leaves and Flowers of Callistemon citrinus from Western Himalayas A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export.Safeguarding entry into mitosis: the antephase checkpoint.Inhibition of cell proliferation and migration by miR-509-3p that targets CDK2, Rac1, and PIK3C2A.Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032 Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity.Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition.Coupling of the cell cycle and apoptotic machineries in developing T cells.Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells Identification of the nuclear localization signal in Xenopus cyclin E and analysis of its role in replication and mitosis.Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells.Origin licensing and programmed cell death: a hypothesis.Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitis.MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2 cAMP signaling regulates histone H3 phosphorylation and mitotic entry through a disruption of G2 progression.Yang-Dan-Tang, Identified from 15 Chinese Herbal Formulae, Inhibits Human Lung Cancer Cell Proliferation via Cell Cycle Arrest.Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma.Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells.CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.Selenium in bone health: roles in antioxidant protection and cell proliferation.Mammalian interphase cdks: dispensable master regulators of the cell cycle.Emerging drug profile: cyclin-dependent kinase inhibitors Selenium as an essential micronutrient: roles in cell cycle and apoptosis.MicroRNA-195 suppresses colorectal cancer cells proliferation via targeting FGF2 and regulating Wnt/β-catenin pathway.Platonin inhibited PDGF-BB-induced proliferation of rat vascular smooth muscle cells via JNK1/2-dependent signaling.miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma.pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner.Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases.IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation.Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition.Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts.Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.Putting one step before the other: distinct activation pathways for Cdk1 and Cdk2 bring order to the mammalian cell cycle

P2860

Q24681581-D35521FA-188E-4DE2-86FC-A4E6168BB96F Q24802591-9D4F714A-FAE6-4C82-B3A5-AAB9C60AA356 Q27332338-32622185-A220-48CB-A6CE-207225851B4A Q28274303-4C5599C6-6C8D-47C9-9A11-13D1273A0858 Q28547515-CB4F3807-C462-4DF5-972E-A03F3AB30F6F Q30492543-1134CF52-511A-4991-A327-658294B93E79 Q33558235-DEA17806-55F2-476F-855F-6730A34A0415 Q33574284-39CA1270-26DA-446E-94AF-C433ED9E8412 Q33642396-CAAB7B8E-B433-473C-B2DC-5DA4D711FD0E Q33724384-0BCF4188-080F-43A6-AAFB-C109E77534FF Q33735526-20993A54-AD98-415D-BC56-696A3BEC8DF8 Q33748166-507F0EB9-5753-476A-BD15-8EC1B1678405 Q33866583-0C38DCCE-3411-4D48-8311-82592F1E188D Q34295315-72F20349-69DE-4E8A-B922-FBF03C928014 Q34417402-71E7F966-1406-41D7-86E4-4E63D0232EE5 Q34590906-8396C382-5E0E-4AC6-B54F-F7C6C0490A80 Q34786469-3323950C-2038-4438-92A3-1DCD0B05CD06 Q35082180-309CBFC8-B707-4F79-920F-D131E1799559 Q35111108-F72D9A35-74F2-41E6-9D18-AAAC7947492F Q35220766-01FFD08B-A18E-44FA-B7E9-69F43622DABE Q35559957-BF30B8A9-175B-46D2-AD88-E5334D791061 Q36014834-D67E736D-1E09-4014-9F83-E78F6E26ACE6 Q36140240-3F72FD63-473A-42CC-8C1C-7C9A58F88279 Q36189534-AAC1BA81-5F7D-4F69-AE5C-5EDB4C0FB490 Q36448119-6B51F2A4-CD8D-45AD-96E7-7E605F771C42 Q36607654-66466D73-FD4D-44C6-8C83-A32287F117E1 Q36796448-665C3B21-55A0-41E0-B438-9AA7792EB104 Q37185372-5D546E1B-888E-486B-933D-05F952ED6310 Q37424788-5557B0C5-753E-452B-8109-C97BDFA0A01B Q37447925-A29D4C21-68EE-4B91-A70D-F954293356DA Q37728747-3C55FCCF-C790-4446-B9D7-AA447A023E4B Q38753529-8A250A02-D6EA-4961-9878-ED2748F10FEA Q39042925-F7F2A740-D8B8-40FA-9961-717F80272A44 Q39154743-561F8C6C-DFEE-4ED9-82F9-128D20EC8099 Q39490067-F7562E73-8802-411E-9E4B-CA88BD6FE304 Q39527654-4EDF19FC-CBF5-4D3E-B649-D29DF0AA0F53 Q39719910-0937D034-091C-46CC-BB83-A2DDE2904DA3 Q39804772-3122B655-3F1D-4B1B-BA0A-98E6CB8A71C7 Q39942131-21BECBCE-9662-40D6-AD2E-59B16B195981 Q39942878-8BC11028-0BC7-48BA-AF42-7CD686A947FC

P2860

S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.

http://www.wikidata.org/entity/Q33941051

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@ast

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@en

type

label

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@ast

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@en

prefLabel

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@ast

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@en

P1433

Q33941051-2B796DA9-6117-45B3-9626-FACEAEC2163A

P1476

Q33941051-62C0D35B-62BC-4E76-84D0-71D72CD44140

P2093

Q33941051-54D179A1-4AF1-40F8-BC83-F48489A09688

Q33941051-6D89DF2D-1C25-4D1A-8929-BE625298911D

Q33941051-B80C626D-803B-445D-8DBF-B9458F10B7E7

Q33941051-FC5E2829-2488-4575-946D-E533ADE588CB

P2860

Q33941051-02F4306A-8153-4A1F-801C-C1D41E6DA620

Q33941051-036022B0-12BE-41AC-BC33-9E8C040D3326

Q33941051-0911F33D-D447-46C4-8AE7-5FBE22B91D25

Q33941051-0A30DEB5-F70E-4A53-B8E5-AAAA9FA49012

Q33941051-0E603E9A-4B82-49F2-8DA1-264EE58F20DF

Q33941051-0F19FC6C-A467-422C-8AF6-20FCABC8F2CB

Q33941051-1995EE63-27A7-4E3E-B0E5-9365FDA45718

Q33941051-1E81163D-DDD4-4574-A6BC-667B16CA60DE

Q33941051-22182EA4-5A4E-4954-A6E5-65B9E1EBAB9C

Q33941051-23834C91-8AB9-4C1C-9DF7-0532FD65D23A

P304

Q33941051-824E9E13-8D7F-4CA9-B523-C336D9510418

P31

Q33941051-3AFEC1D6-82F3-474E-9132-C3212F209722

P356

Q33941051-F4034415-23CC-40E6-B2A5-3F532A40BF54

P407

Q33941051-74BA4B06-7842-4660-8B24-1F0A33A31574

P433

Q33941051-E67673C8-E4D5-4AB2-9176-4EE1022F4C62

P478

Q33941051-B1098353-912A-433F-B69D-4B87CA21F309

P577

Q33941051-5EF2584F-D7EC-47B5-8C9A-E87CCAA0D0DF

P698

Q33941051-D81C143D-6D05-476C-B59A-E70EB93551E8

P932

Q33941051-F3AE14C8-0686-4EB1-956E-B213B1BBD779

P356

MCB.21.8.2755-2766.2001

P1433

Molecular and Cellular Biology

P1476

S and G2 phase roles for Cdk2 ...... egative mutant in human cells.

@en

P2093

B Hu

http://www.w3.org/2001/XMLSchema#string

G H Enders

http://www.w3.org/2001/XMLSchema#string

J Mitra

http://www.w3.org/2001/XMLSchema#string

S van den Heuvel

http://www.w3.org/2001/XMLSchema#string

P2860

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

Chfr defines a mitotic stress checkpoint that delays entry into metaphase

A family of human cdc2-related protein kinases

Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase

Cyclin A is required at two points in the human cell cycle

Cdc6 protein causes premature entry into S phase in a mammalian cell-free system.

Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization

BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

P304

2755-2766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.21.8.2755-2766.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11283255

http://www.w3.org/2001/XMLSchema#string

P932

86906

http://www.w3.org/2001/XMLSchema#string